Aerie Pharmaceuticals Announces Appointment of New Members of its Research and Development Team
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of 11 employees to its Research and Development team located in Durham, NC. The new employees will initially focus on preclinical activities associated with the drug delivery asset acquisition from Envi